NCT07275957

Brief Summary

This study aims to evaluate the effects of a combined dietary-nutritional and physical exercise intervention on physical, physiological, and psychological outcomes in women who are breast cancer survivors. Participants will be randomly assigned to different intervention groups involving dietary modification, exercise training, or their combination, compared to a control group. The program will last 12 weeks and will include pre- and post-intervention assessments of body composition, metabolic parameters, functional capacity, and quality of life. The primary goal is to assess improvements in physical fitness, body composition, and emotional well-being, as well as to identify potential synergistic effects of combined interventions in this population.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
1mo left

Started Sep 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Sep 2023Jun 2026

Study Start

First participant enrolled

September 1, 2023

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

November 25, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

December 10, 2025

Completed
21 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Expected
Last Updated

February 4, 2026

Status Verified

February 1, 2026

Enrollment Period

2.3 years

First QC Date

November 25, 2025

Last Update Submit

February 3, 2026

Conditions

Keywords

Breast cancer survivorsExercise interventionNutritional interventionMediterranean dietPhysical rehabilitationQuality of lifeBody compositionStrength trainingAerobic exerciseCombined trainingLifestyle modification

Outcome Measures

Primary Outcomes (1)

  • Change in Fat-Free Mass (kg)

    To evaluate changes in fat-free mass after the 12-week intervention, measured by bioimpedance analysis (BIODY XPERT ZM).

    Baseline and Week 12

Secondary Outcomes (21)

  • Change in Fat Mass (%)

    Baseline and Week 12

  • Change in Body Weight (kg)

    Baseline and Week 12

  • Change in Body Mass Index (kg/m²)

    Baseline and Week 12

  • Change in Waist Circumference (cm)

    Baseline and Week 12

  • Change in Handgrip Strength (kg)

    Baseline and Week 12

  • +16 more secondary outcomes

Study Arms (6)

Arm 1 - Control Group

NO INTERVENTION

Participants will not receive any specific dietary or exercise intervention. They will be asked to maintain their usual lifestyle and dietary habits during the 12-week study period. General health recommendations based on national guidelines will be provided at baseline.

Arm 2 - Mediterranean Diet Group (MD)

EXPERIMENTAL

Participants will receive individualized nutritional counseling promoting adherence to a Mediterranean dietary pattern, emphasizing fruits, vegetables, legumes, whole grains, olive oil, nuts, fish, and moderate dairy intake. Processed and high-sugar foods will be limited. Dietitians will provide personalized follow-up and adjustments every two weeks to ensure adherence.

Behavioral: Mediterranean Diet Counseling

Arm 3 - Strength Training Group (ST)

EXPERIMENTAL

Participants will perform a 12-week supervised resistance training program focused on improving muscular strength and functional capacity. Sessions will be conducted three times per week, lasting approximately 60 minutes, and include major muscle groups using elastic bands, free weights, and bodyweight exercises. Training load will progressively increase according to individual capacity.

Behavioral: Supervised Strength Training Program

Arm 4 - Endurance Training Group (ET)

EXPERIMENTAL

Participants will follow a structured aerobic exercise program consisting of walking, cycling, or treadmill sessions three times per week for 12 weeks. The intensity will be moderate (60-75% of estimated maximal heart rate), gradually progressing as tolerated. The goal is to enhance cardiorespiratory fitness and overall endurance.

Behavioral: Supervised Endurance Training Program

Arm 5 - Combined Training Group (CT)

EXPERIMENTAL

Participants will perform both strength and aerobic training during the 12-week intervention. Each session (3 per week, 60-70 minutes) will include resistance exercises targeting major muscle groups followed by aerobic activity at moderate intensity. The program aims to improve both muscular and cardiovascular performance synergistically.

Behavioral: Combined Strength and Endurance Training Program

Arm 6 - Mediterranean Diet plus Combined Training Group (MD+CT)

EXPERIMENTAL

Participants will simultaneously receive the Mediterranean Diet counseling and participate in the Combined Training program for 12 weeks. The objective is to assess the synergistic effects of diet and exercise on physical, physiological, and psychological health in breast cancer survivors.

Behavioral: Combined Mediterranean Diet and Exercise Program

Interventions

Individualized nutritional counseling based on Mediterranean diet principles, emphasizing the intake of fruits, vegetables, legumes, whole grains, nuts, olive oil, and fish, while reducing red meat, processed foods, and added sugars. Sessions will be held biweekly to ensure adherence and promote long-term dietary behavior change.

Arm 2 - Mediterranean Diet Group (MD)

A structured resistance exercise program performed three times per week for 12 weeks. Each 60-minute session will include exercises for major muscle groups using elastic bands, dumbbells, or body weight, progressively increasing intensity to improve muscle strength and endurance.

Arm 3 - Strength Training Group (ST)

A structured aerobic exercise program consisting of walking, cycling, or treadmill training three times per week for 12 weeks. Exercise intensity will range from 60% to 75% of the estimated maximal heart rate, progressively adjusted to enhance cardiovascular fitness and fatigue resistance.

Arm 4 - Endurance Training Group (ET)

A combined exercise protocol including both resistance and aerobic components within each 60-70-minute session, three times per week for 12 weeks. Strength exercises will precede moderate-intensity aerobic work to improve overall physical performance and functional capacity.

Arm 5 - Combined Training Group (CT)

Comprehensive lifestyle intervention combining Mediterranean diet counseling with the supervised combined training program. Participants will receive individualized diet plans and attend three supervised exercise sessions per week. The intervention targets improvements in body composition, physical fitness, and emotional well-being.

Arm 6 - Mediterranean Diet plus Combined Training Group (MD+CT)

Eligibility Criteria

Age30 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women aged 30 to 65 years.
  • Previous diagnosis of breast cancer (stages I-III) confirmed by medical records.
  • Completion of primary oncological treatment (surgery, radiotherapy, chemotherapy, and/or hormone therapy) at least 3 months before enrollment.
  • Absence of active cancer or evidence of recurrence.
  • Medical clearance to perform physical exercise.
  • Willingness to participate in dietary and/or exercise interventions for 12 weeks.
  • Ability to attend evaluation and intervention sessions and comply with study procedures.
  • Signed written informed consent.

You may not qualify if:

  • Active cancer, metastasis, or ongoing chemotherapy or radiotherapy.
  • Severe cardiovascular, respiratory, renal, hepatic, or metabolic disease that contraindicates exercise.
  • Musculoskeletal or neurological conditions limiting participation in physical activity.
  • Severe psychiatric disorders or cognitive impairment affecting adherence to the intervention.
  • Current participation in another clinical trial or structured lifestyle intervention.
  • Use of dietary supplements, appetite regulators, or pharmacological agents affecting metabolism during the study period.
  • Pregnancy, breastfeeding, or intention to become pregnant during the study.
  • Inability to comply with the intervention schedule or follow-up assessments.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

European Institute Of Exercise and Health

Elche, Alicante, 03203, Spain

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned to one of six parallel intervention arms (control, Mediterranean diet, strength training, endurance training, combined training, or Mediterranean diet plus combined training). The interventions will be carried out simultaneously over 12 weeks, with pre- and post-intervention assessments to evaluate changes in physical, physiological, and psychological parameters.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Full Professor of Health Sciences

Study Record Dates

First Submitted

November 25, 2025

First Posted

December 10, 2025

Study Start

September 1, 2023

Primary Completion

December 31, 2025

Study Completion (Estimated)

June 30, 2026

Last Updated

February 4, 2026

Record last verified: 2026-02

Locations